Skip to content
(416) 978-6381info@eplink.ca
Twitter page opens in new windowFacebook page opens in new windowYouTube page opens in new window
EpLink
The Epilepsy Research Program of the Ontario Brain Institute
EpLink
  • Home
  • About Us
    • Who We Are
    • Management Committee
    • Community Advisory Committee
    • External Advisors
    • Contact Us
  • Research
    • Current Projects
    • Past Research
  • Resources
    • Newsletters & Research Updates
    • What is Epilepsy?
    • Types of Seizures
    • Guidelines & Infographics
    • Teacher Tool Kit
    • COVID-19 and Epilepsy
  • Events
  • Media
    • Press Releases
    • Media Coverage
    • Contact Us
Search:
  • Home
  • About Us
    • Who We Are
    • Management Committee
    • Community Advisory Committee
    • External Advisors
    • Contact Us
  • Research
    • Current Projects
    • Past Research
  • Resources
    • Newsletters & Research Updates
    • What is Epilepsy?
    • Types of Seizures
    • Guidelines & Infographics
    • Teacher Tool Kit
    • COVID-19 and Epilepsy
  • Events
  • Media
    • Press Releases
    • Media Coverage
    • Contact Us

Daily Archives: February 20, 2019

You are here:
  1. Home
  2. 2019
  3. February
  4. 20

EpLink and Aurora Cannabis to partner on study for adults with drug-resistant epilepsy

Press ReleasesBy EpLinkFebruary 20, 20191 Comment

First adult study in Canada to examine the impact of cannabis oil on the reduction of convulsive seizures Toronto, ON – February 20, 2019 – EpLink – The Epilepsy Research Program of the Ontario Brain Institute – in collaboration with Aurora Cannabis’ wholly owned subsidiary MedReleaf – today announced the initiation of a clinical study…

© EpLink 2019. All rights reserved.
Go to Top